In light of the vast array of potential target tissues, pharmacological and mechanistic understanding of cell type-specific gene regulation by PPARγ and TZDs will help to design improved diabetic drugs, such as selective PPARγ modulators, which retain high potency to treat diabetes with minimal bone loss side effects [12, 97]. Here, PPARG is linked to diabetes mellitus.